General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis

Published:2014-11-07 Issue:2 Volume:31 Page:353-365
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Shim Sung Ryul¹,Kim Jae Heon²,Choi Hoon³,Lee Won Jin⁴,Kim Hae Joon⁴,Bae Min Young⁵,Hwang Sung Dong⁶,Kim Khae Hwan⁷,Bae Jae Hyun³,Yoon Sang Jin⁷

Affiliation:

1. aDepartment of Epidemiology and Medical Informatics, Korea University, Seoul, Korea

2. bDepartment of Urology, Soonchunhyang University College of Medicine, Seoul, Korea

3. cDepartment of Urology, Korea University College of Medicine, Seoul, Korea

4. dDepartment of Preventive Medicine, Korea University College of Medicine, Seoul, Korea

5. eDepartment of Executive MBA, Korea University Business School, Seoul, Korea

6. fDepartment of Social Welfare, Kyungpook National University College of Social Science, Daegu, Korea

7. gDepartment of Urology, Gil Hospital, Gacheon University College of Medicine, Korea

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2014.980887

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of the effectiveness and safety of different dosages of Glancin (tamsulosin) in the treatment of patients with lower urinary tract symptoms due to benign prostatic hyperplasia;Urology reports (St. - Petersburg);2023-01-22

2. Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker: An assessor-blinded, randomized, controlled pilot study;Medicine;2022-09-09

3. Impact of drug use on patient symptom score and quality of life in benign prostatic hyperplasia patients;Journal of Primary Care Specialties;2022

4. Bilateral electrical pudendal nerve stimulation as additional therapy for lower urinary tract dysfunction when stage II sacral neuromodulator fails: a case report;BMC Urology;2021-03-10

5. The effectiveness and safety of moxibustion for treating benign prostatic hyperplasia;Medicine;2020-09-04